Home › PsychoGenics And The Alzheimer's Drug Discovery Foundation Announce A Risk-Sharing Partnership For Preclinical Studies
 

Keywords :   


PsychoGenics And The Alzheimer's Drug Discovery Foundation Announce A Risk-Sharing Partnership For Preclinical Studies

2016-02-03 03:43:39| drugdiscoveryonline Home Page

PsychoGenics Inc. and the Alzheimer's Drug Discovery Foundation (ADDF) announce a new partnership to bring PsychoGenics' validated Alzheimer's animal models and experimental services to ADDF grantees working on preclinical Alzheimer's drug discovery programs

Tags: studies foundation drug partnership

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
24.11Portrait.Of.Pirates ver2.5
24.11Switch
24.11 / TIN
24.11duranduranALMGHTY 26.5cm
24.11straykids skzoo
24.11 4
24.11 TrioTryiT Figure21
24.11
More »